Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

European Innovation Council · Running

HYDRUSTENT Hydrogel Biodegradable Ureteral Stent

Coordinator
Hydrumedical SA, Portugal
Runs
1 December 2023 to 30 November 2025
Status
Running
EU funding
€1.5m
Total cost
€2.2m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190169028

What the project is doing

In the project's own words, from its summary on CORDIS.

Hydrumedical S.A. (HYD) team is composed by a urologist and biomaterials scientists that will revolutionise the treatment of ureteral disorders. Hydrustent is a biodegradable, hydrogel-based, soft, lubricated, and flexible stent. These properties prevent bacterial adhesion (>80% of the stent-related complications) and encrustation development. Nowadays, the application of stents requires a 2nd removal procedure, a burden for patients and healthcare systems.

Hydrustent is homogeneously degraded by the urine flow within 7-10 days, eliminating the need of further interventions for its removal. Hydrustent will bring huge health benefits for patients and reduce up to 60% of treatment costs (4.3B€ savings for the health system in EU+US). Validated by the urology community, with a global Ureteral Stents Market raising (~604M€ by 2030), if Hydrustent project is successfully implemented, we intend to reach the EU market in 2024 with profits amounting to 25M€, 5 years after product launch.

Topics

Who is involved

OrganisationCityCountryRole
Hydrumedical SAGuimaraesPortugalCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI